Jacqueline S Jeruss

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. ncbi Calcifying fibrous pseudotumor of the breast
    Amrit Mangat
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Breast J 15:299-301. 2009
  2. ncbi Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial
    Jacqueline S Jeruss
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Ann Surg Oncol 18:65-71. 2011
  3. ncbi Staging of breast cancer in the neoadjuvant setting
    Jacqueline S Jeruss
    Department of Surgery, Northwestern University Feinberg School of Medicine and Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA
    Cancer Res 68:6477-81. 2008
  4. ncbi Incorporating fertility preservation into the care of young oncology patients
    Amanda J Redig
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Cancer 117:4-10. 2011
  5. ncbi Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines
    Anne Cooley
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Cell Cycle 9:4900-7. 2010
  6. ncbi Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro
    Anne Cooley
    Department of Surgery, Northwestern University Feinberg School of Medicine, 250 East Superior Street, Prentice, 4 420, Chicago, IL 60611, USA
    Hum Reprod 27:146-52. 2012
  7. ncbi Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib
    Virginia G Kaklamani
    Division of Hematology Oncology, Northwestern University, 676 North St Clair Street, Suite 850, Chicago, IL 60611, USA
    Breast Cancer Res Treat 132:833-42. 2012
  8. ncbi Maintaining fertility in young women with breast cancer
    Melissa C Hulvat
    Department of Surgery, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Lurie, 4 115, Chicago, IL 60611, USA
    Curr Treat Options Oncol 10:308-17. 2009
  9. ncbi Phospho-specific Smad3 signaling: impact on breast oncogenesis
    Elizabeth Tarasewicz
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Cell Cycle 11:2443-51. 2012
  10. ncbi Using decision trees to enhance interdisciplinary team work: the case of oncofertility
    Shauna L Gardino
    Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Suite 10 121, Chicago, IL 60611, USA
    J Assist Reprod Genet 27:227-31. 2010

Detail Information

Publications20

  1. ncbi Calcifying fibrous pseudotumor of the breast
    Amrit Mangat
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Breast J 15:299-301. 2009
    ..We present the first reported case of a CFP in the breast. CFP should be considered in the differential diagnosis for patients presenting with coarse indeterminate calcifications of the breast...
  2. ncbi Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial
    Jacqueline S Jeruss
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Ann Surg Oncol 18:65-71. 2011
    ..We hypothesized that APBI delivered via MammoSite would continue to be well tolerated, associated with a good cosmetic outcome, and carry a low risk for recurrence in patients with DCIS...
  3. ncbi Staging of breast cancer in the neoadjuvant setting
    Jacqueline S Jeruss
    Department of Surgery, Northwestern University Feinberg School of Medicine and Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA
    Cancer Res 68:6477-81. 2008
    ....
  4. ncbi Incorporating fertility preservation into the care of young oncology patients
    Amanda J Redig
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Cancer 117:4-10. 2011
    ..Current guidelines in oncology and reproductive medicine are also reviewed to underscore the importance of communicating fertility preservation options to young patients with cancer...
  5. ncbi Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines
    Anne Cooley
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Cell Cycle 9:4900-7. 2010
    ..Inhibition of CDK2 may lead to restoration of Smad3 tumor suppressor activity in breast cancer cells, and may represent a potential treatment approach for cyclin E overexpressing breast cancers...
  6. ncbi Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro
    Anne Cooley
    Department of Surgery, Northwestern University Feinberg School of Medicine, 250 East Superior Street, Prentice, 4 420, Chicago, IL 60611, USA
    Hum Reprod 27:146-52. 2012
    ..Our goal was to understand the association between infertility treatment and normal and cancerous breast cell proliferation...
  7. ncbi Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib
    Virginia G Kaklamani
    Division of Hematology Oncology, Northwestern University, 676 North St Clair Street, Suite 850, Chicago, IL 60611, USA
    Breast Cancer Res Treat 132:833-42. 2012
    ..This combination offers an alternative non-anthracycline-containing regimen for women with HER2 positive breast cancer...
  8. ncbi Maintaining fertility in young women with breast cancer
    Melissa C Hulvat
    Department of Surgery, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Lurie, 4 115, Chicago, IL 60611, USA
    Curr Treat Options Oncol 10:308-17. 2009
    ..Causes of ovarian suppression and options for treatment, including consideration of preimplantation genetic diagnosis and alternative parenting approaches are also discussed to assist the clinician caring for young patients with cancer...
  9. ncbi Phospho-specific Smad3 signaling: impact on breast oncogenesis
    Elizabeth Tarasewicz
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Cell Cycle 11:2443-51. 2012
    ..This review highlights recent advances revealing the critical role of phospho-specific Smad3 in malignancy and illustrates the potential prognostic and therapeutic impact of Smad3 phospho-isoforms in breast cancer...
  10. ncbi Using decision trees to enhance interdisciplinary team work: the case of oncofertility
    Shauna L Gardino
    Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Suite 10 121, Chicago, IL 60611, USA
    J Assist Reprod Genet 27:227-31. 2010
    ..Fertility preservation decisions must be made before treatment begins, adding stress to the decision-making process...
  11. ncbi Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology
    Daniel E Abbott
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Cancer Biol Ther 9:23-30. 2010
    ....
  12. ncbi Multidisciplinary care for patients with breast cancer
    Melissa C Hulvat
    Northwestern University Feinberg School of Medicine, Department of Surgery, Chicago, IL 60611, USA
    Surg Clin North Am 89:133-76, ix. 2009
    ....
  13. ncbi Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells
    Stanislav Zelivianski
    Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Mol Cancer Res 8:1375-87. 2010
    ..Targeted inhibition of CDK4 activity may have a role in the treatment of cyclin D-overexpressing breast cancers...
  14. ncbi Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy
    Jacqueline S Jeruss
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA
    J Clin Oncol 26:246-52. 2008
    ..We hypothesized that by using clinical and pathologic staging parameters, in conjunction with biologic tumor markers, a novel means of determining prognosis for patients treated with neoadjuvant chemotherapy could be facilitated...
  15. ncbi Bone marrow micrometastases in breast cancer
    Jacqueline S Jeruss
    N Engl J Med 353:2191; author reply 2191. 2005
  16. ncbi Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells
    Joanna E Burdette
    Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208, USA
    Cancer Res 65:7968-75. 2005
    ..These data indicate that activin A inhibits breast cancer cellular proliferation and activates Smads responsible for initiating cell cycle arrest...
  17. ncbi Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast
    Jacqueline S Jeruss
    Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Ann Surg Oncol 13:967-76. 2006
    ..Long-term follow-up data regarding patient satisfaction, cosmesis, and efficacy are needed and will be determined from a recently opened large randomized study...
  18. ncbi Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?
    Jacqueline S Jeruss
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:2328-36. 2006
    ..The authors hypothesized that TIC, when compared with standard postoperative SLN assessment alone, would permit a cost-effective evaluation of SLNs in patients with clinically node-negative breast cancer...
  19. ncbi Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy
    Jacqueline S Jeruss
    Department Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:2646-54. 2008
    ....
  20. ncbi Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer
    Jacqueline S Jeruss
    Department of Neurobiology and Physiology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois 60208, USA
    Cancer Res 63:3783-90. 2003
    ..Thus, activin signal transduction components are present in normal tissue and grade 1 cancer but down-regulated in high-grade cancer. The deregulation of this signal transduction system may be relevant to advancing oncogenic progression...